Foghorn Therapeutics Inc. (FHTX) Misses Q1 EPS by 11c

Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.30), $0.11 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.95 million versus the consensus estimate of $5.95 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• EagleOne Metals closes $225,199 non-brokered private placement